ORAL MESALAZINE DRUGS FOR ULCERATIVE COLITIS: CURRENT CLINICAL PRACTICE

The article represents the role of oral 5-aminosalicylic acid(5-ASA) drugs in the structure of the basic therapy of ulcerative colitis according to current clinical guidelines. The results of current epidemiological studies reflecting the features of the use of oral preparations 5-ASA in clinical practice in the context of the length of colon lesions are presented, a high frequency of use of monotherapy with oral 5-ASA preparations were noted. The spectrum of currently used oral preparations 5-ASA and their features that determine the flow of the active substance into the mucous membrane of the affected areas of the colon are presented.